RegenETP Future Growth
Future criteria checks 0/6
Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für RegenETP zu prognostizieren.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 20.9% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
PolarityTE down 10% on lower-than-expected Q2 revenue
Aug 12Will PolarityTE (NASDAQ:PTE) Spend Its Cash Wisely?
Mar 08Here's Why We're Watching PolarityTE's (NASDAQ:PTE) Cash Burn Situation
Nov 16PolarityTE Is Not A DeFi Coin
Jul 19Does PolarityTE (NASDAQ:PTE) Have A Healthy Balance Sheet?
Jun 04PolarityTE shares surge 25% after Diabetic Foot Ulcer trial met primary and secondary endpoint
May 10What You Need To Know About PolarityTE, Inc.'s (NASDAQ:PTE) Investor Composition
Feb 19PolarityTE to raise up to $10M with at-the-market offering
Jan 12PolarityTE under pressure on pricing $8M registered direct offering
Dec 22PolarityTE perks up after securing first U.S. patent
Nov 30PolarityTE EPS beats by $0.02, beats on revenue
Nov 09In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RegenETP has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2023 | 0 | -8 | -22 | -22 | N/A |
12/31/2022 | 1 | -8 | -23 | -23 | N/A |
9/30/2022 | 2 | -16 | -26 | -26 | N/A |
6/30/2022 | 3 | -13 | -26 | -26 | N/A |
3/31/2022 | 5 | -17 | -22 | -22 | N/A |
12/31/2021 | 9 | -30 | -23 | -23 | N/A |
9/30/2021 | 12 | -32 | -21 | -21 | N/A |
6/30/2021 | 14 | -38 | -23 | -23 | N/A |
3/31/2021 | 14 | -47 | -31 | -31 | N/A |
12/31/2020 | 10 | -43 | -39 | -38 | N/A |
9/30/2020 | 8 | -54 | -50 | -48 | N/A |
6/30/2020 | 6 | -70 | -55 | -53 | N/A |
3/31/2020 | 5 | -80 | -57 | -55 | N/A |
12/31/2019 | 6 | -92 | -59 | -57 | N/A |
9/30/2019 | 7 | -128 | -70 | -69 | N/A |
6/30/2019 | 7 | -125 | -69 | -66 | N/A |
3/31/2019 | 6 | -116 | -64 | -60 | N/A |
12/31/2018 | 4 | -111 | -53 | -48 | N/A |
10/31/2018 | 2 | -74 | -38 | -29 | N/A |
7/31/2018 | 0 | -62 | -27 | -20 | N/A |
4/30/2018 | 0 | -50 | -20 | -15 | N/A |
1/31/2018 | 0 | -141 | -16 | -12 | N/A |
10/31/2017 | N/A | -131 | -10 | -8 | N/A |
7/31/2017 | N/A | -121 | -7 | -5 | N/A |
4/30/2017 | -1 | -118 | -5 | -3 | N/A |
1/31/2017 | -1 | -8 | N/A | -2 | N/A |
10/31/2016 | N/A | -10 | N/A | -2 | N/A |
7/31/2016 | 0 | -10 | N/A | -2 | N/A |
4/30/2016 | 3 | -9 | N/A | -4 | N/A |
1/31/2016 | 4 | -11 | N/A | -4 | N/A |
10/31/2015 | 7 | -6 | N/A | -2 | N/A |
7/31/2015 | 13 | -11 | N/A | -4 | N/A |
4/30/2015 | 14 | -13 | N/A | -2 | N/A |
1/31/2015 | 16 | -13 | N/A | -2 | N/A |
10/31/2014 | 34 | -16 | N/A | -4 | N/A |
7/31/2014 | 38 | -15 | N/A | -6 | N/A |
4/30/2014 | 39 | -16 | N/A | -13 | N/A |
1/31/2014 | 46 | -15 | N/A | -12 | N/A |
10/31/2013 | 47 | -13 | N/A | -5 | N/A |
7/31/2013 | 64 | -11 | N/A | -8 | N/A |
4/30/2013 | 69 | -10 | N/A | -6 | N/A |
Analyst Future Growth Forecasts
Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von RGTP.Q über der Sparquote liegt (2.2%).
Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von RGTP.Q schneller wachsen werden als der Markt US
Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von RGTP.Q in den nächsten 3 Jahren signifikant steigen werden.
Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von RGTP.Q schneller wachsen werden als der Markt von US.
Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von RGTP.Q schneller wachsen werden als 20% pro Jahr.
Earnings per Share Growth Forecasts
Future Return on Equity
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von RGTP.Q in 3 Jahren voraussichtlich hoch sein wird